Bioscript Group

Bioscript Group is a global healthcare communications and market access agency that supports pharmaceutical and biotechnology companies throughout the product lifecycle. The company provides specialized services in medical communications, regulatory affairs, and value-based market access to help clients demonstrate the clinical and economic value of their therapies. With a focus on scientific rigor and strategic insight, Bioscript assists in the preparation of regulatory submissions, medical writing, and global market entry strategies. The group operates through several specialized divisions, including Bioscript Medical and Bioscript Regulatory, ensuring deep expertise across various therapeutic areas such as oncology and rare diseases. In 2024, the group was acquired by Inizio, integrating its expertise into Inizio's broader medical and commercial platform.